|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BRADLEY ALEC CIGAR CORP/FL, 10SB12G, EX-21, 2000-12-19 |
Next: GENEREX BIOTECHNOLOGY CORP, 10-Q/A, 2000-12-19 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> Dec-31-1999
<PERIOD-START> Jan-01-1999
<PERIOD-END> Sep-30-2000
<CASH> 26,159
<SECURITIES> 0
<RECEIVABLES> 60,289
<ALLOWANCES> 0
<INVENTORY> 72,443
<CURRENT-ASSETS> 187,815
<PP&E> 15,184
<DEPRECIATION> 0
<TOTAL-ASSETS> 209,751
<CURRENT-LIABILITIES> 103,606
<BONDS> 0
0
0
<COMMON> 448
<OTHER-SE> 105,697
<TOTAL-LIABILITY-AND-EQUITY> 209,751
<SALES> 0
<TOTAL-REVENUES> 397,549
<CGS> 269,168
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 129,097
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (716)
<INCOME-TAX> 0
<INCOME-CONTINUING> (716)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (716)
<EPS-BASIC> 0
<EPS-DILUTED> 0
</TABLE>
|
|